ZIM Laboratories Limited (ZIMLAB.NS) NSE
84.37
-2.82(-3.23%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
84.37
-2.82(-3.23%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
556
First IPO Date
November 25, 2022
| Name | Title | Pay | Year Born |
| Chandrashekhar Mainde | Chief Executive Officer & Executive Director | 0 | N/A |
| Zulfiquar Murtaza Kamal | Director of Finance & Executive Director | 9.19M | 1961 |
| Prakash Pralhadrao Sapkal | Head of ODS Business, Formulations of Domestic, ROW & Emerging Markets & Director | 9.89M | 1968 |
| Niraj Pukhraj Dhadiwal | Director of Business Development & Executive Director | 10.02M | 1967 |
| Anwar Siraj Daud | Executive Chairman & MD | 14.67M | N/A |
| Piyush Siddheshwar Nikhade | Company Secretary & Compliance Officer | 0 | N/A |
| Shyam Mohan Patro | Chief Financial Officer | 0 | N/A |
| Vijay Fudke | Senior Vice President of Technical Services | 0 | N/A |
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.